1. Home
  2. AQB vs TOVX Comparison

AQB vs TOVX Comparison

Compare AQB & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AQB
  • TOVX
  • Stock Information
  • Founded
  • AQB 1991
  • TOVX 2001
  • Country
  • AQB United States
  • TOVX United States
  • Employees
  • AQB N/A
  • TOVX N/A
  • Industry
  • AQB
  • TOVX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AQB
  • TOVX Health Care
  • Exchange
  • AQB Nasdaq
  • TOVX Nasdaq
  • Market Cap
  • AQB 3.4M
  • TOVX 3.2M
  • IPO Year
  • AQB N/A
  • TOVX 2006
  • Fundamental
  • Price
  • AQB $0.58
  • TOVX $1.30
  • Analyst Decision
  • AQB Hold
  • TOVX Strong Buy
  • Analyst Count
  • AQB 2
  • TOVX 1
  • Target Price
  • AQB N/A
  • TOVX $6.00
  • AVG Volume (30 Days)
  • AQB 838.2K
  • TOVX 100.1K
  • Earning Date
  • AQB 11-05-2024
  • TOVX 11-12-2024
  • Dividend Yield
  • AQB N/A
  • TOVX N/A
  • EPS Growth
  • AQB N/A
  • TOVX N/A
  • EPS
  • AQB N/A
  • TOVX N/A
  • Revenue
  • AQB $1,258,512.00
  • TOVX N/A
  • Revenue This Year
  • AQB N/A
  • TOVX N/A
  • Revenue Next Year
  • AQB $57.38
  • TOVX N/A
  • P/E Ratio
  • AQB N/A
  • TOVX N/A
  • Revenue Growth
  • AQB N/A
  • TOVX N/A
  • 52 Week Low
  • AQB $0.47
  • TOVX $1.14
  • 52 Week High
  • AQB $3.00
  • TOVX $17.00
  • Technical
  • Relative Strength Index (RSI)
  • AQB 30.45
  • TOVX 48.61
  • Support Level
  • AQB $0.47
  • TOVX $1.23
  • Resistance Level
  • AQB $1.00
  • TOVX $1.21
  • Average True Range (ATR)
  • AQB 0.14
  • TOVX 0.08
  • MACD
  • AQB -0.02
  • TOVX 0.02
  • Stochastic Oscillator
  • AQB 21.18
  • TOVX 72.73

About AQB AquaBounty Technologies Inc.

AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Share on Social Networks: